Monitor the company's future filings for evidence of VITA HEALTH's business development contributions; the rights only become dilutive if the performance condition is met, which is uncertain and subject to board discretion.
Price Chart
Executive Summary
rYojbaba Co., Ltd. issued 346,500 stock acquisition rights (paid stock options) to VITA HEALTH PTE. LTD., an external collaborator, at a nominal subscription price of $0.0080 per right ($2,772 total). Each right entitles the holder to purchase one share at $3.50, exercisable from January 1, 2027 to December 31, 2028, but only if the holder generates at least JPY 100 million (~$631,000) in Contribution Profit for the company. The filing is routine — a performance-based equity incentive for a business development partner with no immediate cash impact and highly contingent dilution.
Key Facts
- 346,500 stock acquisition rights issued to VITA HEALTH PTE. LTD. at $0.0080 per right ($2,772 total).
- Exercise price of $3.50 per share; if all exercised, aggregate proceeds would be $1,212,750.
- Exercise period: January 1, 2027 to December 31, 2028.
- Exercise condition: Holder must generate cumulative Contribution Profit of at least JPY 100,000,000 (~$631,000) by December 31, 2028.
- Contribution Profit defined as net sales directly brought to the company less direct expenses, per management accounting rules.
- Rights are non-transferable without board approval and may be acquired for no consideration if conditions are not met.
- Allotment date: October 30, 2026.
Financial Impact
Immediate cash inflow of $2,772 from subscription; potential future proceeds of $1,212,750 if all rights exercised, contingent on performance condition.
Risk Factors
- Potential dilution of up to 346,500 shares if exercise conditions are met.
- Exercise condition is subjective and determined by the board, creating uncertainty for investors.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-047226 |
| Document: form6-k.htm | 0001493152-26-047226 |
| Document: 0001493152-26-047226-index-headers.html | 0001493152-26-047226 |
| Document: 0001493152-26-047226-index.html | 0001493152-26-047226 |
| Document: 0001493152-26-047226.txt | 0001493152-26-047226 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 6-K | $2.70 | awaiting T+20 | — | $2.17 (−19.63%) |
Mar 30, 2026 30w ago | 6-K | $2.15 $2.02 | ▼ −6.05% | ▼ −18.64% | $2.17 (+0.93%) |
Mar 3, 2026 33w ago | Press Release | $2.75 $2.29 | ▼ −16.73% | ▼ −12.32% | $2.17 (−21.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers